NEUROPACE, INC. Earnings Per Share (Basic)
NEUROPACE, INC. (NPCE) reported Earnings Per Share (Basic) of -$0.18 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- NEUROPACE, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.18.
- NEUROPACE, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.20.
- NEUROPACE, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.08.
- NEUROPACE, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.11.
- NEUROPACE, INC. earnings per share, basic for fiscal 2025 was -$0.66.
- NEUROPACE, INC. earnings per share, basic for fiscal 2024 was -$0.93.
- NEUROPACE, INC. earnings per share, basic for fiscal 2023 was -$1.27.
- NEUROPACE, INC. earnings per share, basic for fiscal 2022 was -$1.91.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.18 10-Q · filed 2026-08-11 | -$0.38 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | -$0.20 10-Q · filed 2026-05-12 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.66 10-K · filed 2026-03-03 |
| 2025-09-30 | -$0.11 10-Q · filed 2025-11-04 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.58 10-Q · filed 2025-11-04 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.26 10-Q · filed 2026-08-11 | -$0.47 10-Q · filed 2026-08-11 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.21 10-Q · filed 2026-05-12 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-05-12 |
| 2024-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.93 10-K · filed 2026-03-03 |
| 2024-09-30 | -$0.19 10-Q · filed 2025-11-04 | -$0.44 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.76 10-Q · filed 2025-11-04 | -$0.99 derived: net income ÷ weighted average shares · filed 2025-11-04 |
| 2024-06-30 | -$0.26 10-Q · filed 2025-08-12 | -$0.58 10-Q · filed 2025-08-12 | -$0.81 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$1.09 derived: net income ÷ weighted average shares · filed 2025-08-12 |
| 2024-03-31 | -$0.32 10-Q · filed 2025-05-13 | -$0.55 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$0.83 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.18 derived: net income ÷ weighted average shares · filed 2025-05-13 |
| 2023-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$0.51 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$0.87 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$1.27 10-K · filed 2025-03-04 |
| 2023-09-30 | -$0.28 10-Q · filed 2024-11-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.05 10-Q · filed 2024-11-12 | -$1.49 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.36 10-Q · filed 2024-08-13 | -$0.77 10-Q · filed 2024-08-13 | -$1.22 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$1.69 derived: net income ÷ weighted average shares · filed 2024-08-13 |
| 2023-03-31 | -$0.41 10-Q · filed 2024-05-08 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$1.34 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$1.86 derived: net income ÷ weighted average shares · filed 2024-05-08 |
| 2022-12-31 | -$0.45 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$0.93 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$1.44 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$1.91 10-K · filed 2024-03-05 |
| 2022-09-30 | -$0.48 10-Q · filed 2023-11-06 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-11-06 | -$1.47 10-Q · filed 2023-11-06 | -$1.91 derived: net income ÷ weighted average shares · filed 2023-11-06 |
| 2022-06-30 | -$0.52 10-Q · filed 2023-08-08 | -$0.99 10-Q · filed 2023-08-08 | -$1.43 derived: net income ÷ weighted average shares · filed 2023-08-08 | -$1.77 derived: net income ÷ weighted average shares · filed 2023-08-08 |
| 2022-03-31 | -$0.47 10-Q · filed 2023-05-04 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-05-04 | -$1.25 derived: net income ÷ weighted average shares · filed 2023-05-04 | -$1.72 derived: net income ÷ weighted average shares · filed 2023-05-04 |
| 2021-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$1.24 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$2.17 10-K · filed 2023-03-02 |
| 2021-09-30 | -$0.34 10-Q · filed 2022-11-08 | -$0.80 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.81 10-Q · filed 2022-11-08 | -$2.85 derived: net income ÷ weighted average shares · filed 2022-11-08 |
| 2021-06-30 | -$0.48 10-Q · filed 2022-08-11 | -$1.93 10-Q · filed 2022-08-11 | -$3.65 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$5.66 derived: net income ÷ weighted average shares · filed 2022-08-11 |
| 2021-03-31 | -$32.73 10-Q · filed 2022-05-12 | -$56.15 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$76.36 derived: net income ÷ weighted average shares · filed 2022-05-12 | |
| 2020-12-31 | -$22.08 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$41.39 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$117.85 10-K · filed 2022-03-10 | |
| 2020-09-30 | -$19.26 10-Q · filed 2021-11-10 | -$96.02 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$43.44 10-Q · filed 2021-08-12 | -$76.76 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$33.32 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |